← back to search

Thomas Starkey

University of Liverpool · GB
Area of research
Infectious Diseases · Oncology
Research interest
Research interests include COVID-19 and healthcare impacts, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, and Cancer Immunotherapy and Biomarkers.
h-index
14
citations
2,682
works
45
NIH funding
—
primary concept
Medicine
email
t.starkey@liverpool.ac.uk

Recent publications

Systematic review and meta‐analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of <scp>COVID</scp>‐19 in immunocompromised patients
British Journal of Haematology 2023cited by 40position: middledoi
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
The Lancet 2020cited by 1,142position: middledoi
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
The Lancet Oncology 2020cited by 599position: middledoi
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals
Nature Immunology 2020cited by 136position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Antonio Pagliuca · King's College - North Carolina1 papers (2023–2023)Maria C. Ionescu · UK Health Security Agency1 papers (2023–2023)Rhea Suribhatla · Thomas Jefferson University1 papers (2023–2023)Lennard Y. W. Lee · Churchill Hospital1 papers (2023–2023)Alex Richter · University of Birmingham1 papers (2023–2023)